Ann-Kathrin Schäfer
5PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 27, 2024
Urinary Dickkopf-3 as a Potential Marker for Estimated Glomerular Filtration Rate Decline in Patients With Heart Failure.Dennis Pieper, Anja Sandek, Ann-Kathrin Schäfer
|Jul 06, 2024
Effects of baroreflex activation therapy on cardiac function and morphology.Ann-Kathrin C Schäfer, Manuel Wallbach, Charlotte Schroer
|Feb 11, 2023
Urinary Dickkopf-3 (DKK3) Is Associated with Greater eGFR Loss in Patients with Resistant Hypertension.Ann-Kathrin C Schäfer, Dennis Pieper, Hassan Dihazi
|Jul 23, 2022
Impact of medication adherence on the efficacy of Baroreflex activation therapy.Ann-Kathrin C Schäfer, Dieter Müller, Ellen Born
|Jun 08, 2021
Eligibility for Baroreflex Activation Therapy and medication adherence in patients with apparently resistant hypertension.Ann-Kathrin Schäfer, Tim Kuczera, Rebecca Wurm-Kuczera
Pageof 1
